polyclonal goat anti mouse dpp4 (R&D Systems)
Structured Review

Polyclonal Goat Anti Mouse Dpp4, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 67 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+polyclonal+anti+dpp4/Mouse+DPPIV%2FCD26+Antibody/pm37216093-172-4-9
Average 93 stars, based on 67 article reviews
Images
1) Product Images from "Pancreas-derived DPP4 is not essential for glucose homeostasis under metabolic stress."
Article Title: Pancreas-derived DPP4 is not essential for glucose homeostasis under metabolic stress.
Journal: iScience
doi: 10.1016/j.isci.2023.106748
Figure Legend Snippet: Figure 2. Islets from HFD-fed Dpp4b-cell/ mice have significantly reduced islet DPP4 activity and expression (A) mRNA abundance of Dpp4 in islets isolated from 52-week-old wild-type C57BL/6J mice fed chow or a high-fat diet. (B) DPP4 activity normalized to total protein in isolated islets from young female mice fed chow or high-fat diet (5 weeks). (C and D) Active GLP-1 and insulin in perfusate from islets of WT male and female mice fed chow or HFHC (12 weeks) diets exposed to 16.7 mM and 10 mM glucose in dynamic perifusion. (E) Insulin content measured in the pancreas of 12-week-old Dpp4+/+ or Dpp4/ littermate controls fed chow or HFD (4 weeks). (F) DPP4 activity normalized to total protein measured in whole extracts of tissues (liver, spleen, gut, heart, pancreas, islets) control (WT, MIP-Cre, Dpp4fl/fl) and Dpp4b-cell/ male mice. (G and H) Plasma DPP4 activity (G) and concentration (H) in plasma of HFD-fed control and Dpp4b-cell/ male mice.
Techniques Used: Activity Assay, Expressing, Isolation, Control, Clinical Proteomics, Concentration Assay
Figure Legend Snippet: Figure 3. Elimination of b cell-derived DPP4 does not improve glucose tolerance and insulin tolerance or prevent incretin degradation in male HFD-fed mice (A–D) Oral glucose tolerance (A) and plasma active GIP (B), active GLP-1 (C), and insulin (D) in male HFD-fed Dpp4b-cell/ and MIP-Cre control mice in response to oral glucose gavage G sitagliptin. (E–G) Intraperitoneal (i.p.) glucose tolerance (E) and plasma active GIP (F), and insulin (G) secreted in response to i.p. glucose injection. Sitagliptin was given by oral gavage 30 min prior to glucose tolerance tests (2 g/kg body weight). (H) Glucose levels and AUC during an insulin (0.6 IU/kg) tolerance test in male, HFD-fed mice. (I) Insulin tolerance test glycemia as a percentage of fasted glucose and AUC. (J) Insulin secretion measured in perifusion of islets from 65-week-old HFD-fed Dpp4b-cell/ (n = 4) and MIP-Cre control (n = 4) mice with arginine (1 mM), GLP-1 (0.3 mm) and GIP (100 nM). Graphs were analyzed by one-way ANOVA (A, E AUCs), unpaired t test (H, I AUCs), or mixed-effects analysis with Tukey’s multiple comparisons. All data are represented as the mean G SEM, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Techniques Used: Derivative Assay, Clinical Proteomics, Control, Injection
Figure Legend Snippet: Figure 4. Elimination of b cell-derived DPP4 does not improve glucose tolerance, incretin levels, or GSIS in HFD-fed female mice (A–C) Oral glucose tolerance (A), active GIP (B), and insulin secreted (C) in female HFD-fed Dpp4b-cell/ and MIP-Cre control mice in response to oral glucose gavage G sitagliptin. (D–F) Intraperitoneal (i.p.) glucose tolerance (D), active GIP (E), and insulin secreted (F) in female HFD-fed Dpp4b-cell/ and MIP-Cre control mice in response to i.p. glucose injection. Sitagliptin was given by oral gavage 30 min prior to glucose tolerance tests (2 g/kg body weight for oGTT and at 1.2 g/kg for ipGTT) (n = 7–10 per group). (G) Glucose levels and AUC during an insulin (0.6 IU/kg) tolerance test in female HFD-fed Dpp4b-cell/ and MIP-Cre control mice. (H) Insulin tolerance test glycemia as a percentage of fasted glucose and AUC. (I) GSIS measured during perifusion of islets isolated from 65-week-old HFD-fed Dpp4b-cell/ (n = 4) and MIP-Cre control (n = 4) mice with arginine (1 mM), GLP-1 (0.3 mm) and GIP (100 nM). AUC graphs represent area under the curve, analyzed by ANOVA with post-hoc Tukey test (A, D) or unpaired t test (G, H). For non-AUC graphs we used mixed-effects analysis with Tukey’s multiple comparisons. All data are represented as the mean G SEM, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Techniques Used: Derivative Assay, Control, Injection, Isolation
Figure Legend Snippet: Figure 5. Ablation of whole pancreas Dpp4 does not improve glucose tolerance or GSIS (A) Immunofluorescence staining of glucagon (purple) and DPP4 (green) and insulin (purple) and DPP4 (green) in HFD-fed mouse pancreatic sections of PDX- Cre and Dpp4Pan/. DAPI staining (blue) was used to identify nuclei. (B) Absolute mRNA abundance of Dpp4 in islets isolated from one-year-old control (Dpp4(fl/fl)) and Dpp4Pan/ male and female mice. (C and D) Glycemia and AUC glucose during (C) oral and (D) i.p. glucose tolerance tests in HFD-fed control and Dpp4Panl/ male mice. (E) Perifusion GSIS in male mice fed HFD for 25–30 weeks, with and without Exendin 9-39. (F and G) Glycemia and AUC glucose during (F) oral and (G) i.p. glucose tolerance tests in HFD-fed control and Dpp4Pan/ female mice. (H) Perifusion GSIS in female mice fed HFD for 25–30 weeks, with and without Exendin 9-39 (100 nM). Statistical analysis was done with mixed-effects analysis and Tukey’s multiple comparisons (C–H), one-way ANOVA (AUC E and H) or unpaired t test (B, AUC C, D, F and G). All data are represented as the mean G SEM, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Scale bars represent 50 mm.
Techniques Used: Staining, Isolation, Control
![Amino acid sequences of the NH 2 -terminal region of the IFN-inducible chemokine and the cleavage site by <t>DPP4.</t> ( A ). DPP4, also known as <t>CD26,</t> is a serine protease capable of enzymatic removal of the first two amino acids from a protein that possesses proline (P) or alanine (A) in the penultimate NH 2 -terminal position. The first two amino acids of mouse CXCL10 are enzymatically cleaved by DPP4. The truncated form of CXCL10 loses its chemotactic activity and possibly functions as an antagonist that binds to its receptor, CXCR3 [ , ]. ( B ). Amino acid sequence of NH 2 -terminal region of the human IFN-inducible chemokine and the cleavage site by DPP4. These amino acid sequences were obtained from UniProt ( https://www.uniprot.org ; accessed on 25 September 2021).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_4432/pmc10204432/pmc10204432__medsci-11-00031-g004.jpg)

